Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,305 | 1,204 | 1,246 | 1,306 | 1,367 | 1,335 | 1,475 | 1,507 | 1,644 | 2,151 | 2,594 | 2,684 |
| Expenses | 997 | 925 | 955 | 1,004 | 1,058 | 1,027 | 1,118 | 1,171 | 1,243 | 1,786 | 2,086 | 2,216 |
| Operating Profit | 308 | 279 | 291 | 302 | 309 | 307 | 358 | 337 | 401 | 365 | 508 | 468 |
| OPM % | 24% | 23% | 23% | 23% | 23% | 23% | 24% | 22% | 24% | 17% | 20% | 17% |
| Other Income | 18 | 18 | 26 | 24 | 23 | 18 | 20 | 24 | 24 | -29 | 25 | 35 |
| Interest | 23 | 25 | 28 | 34 | 35 | 37 | 41 | 45 | 42 | 65 | 91 | 87 |
| Depreciation | 55 | 63 | 65 | 61 | 65 | 70 | 82 | 84 | 87 | 122 | 154 | 156 |
| Profit before tax | 248 | 209 | 225 | 231 | 232 | 219 | 254 | 232 | 296 | 149 | 288 | 260 |
| Tax % | 9% | 10% | 15% | 13% | 14% | 12% | 22% | 15% | 13% | 15% | 22% | 20% |
| Net Profit | 227 | 188 | 191 | 202 | 199 | 193 | 197 | 197 | 258 | 127 | 224 | 207 |
| EPS in Rs | 11.09 | 9.20 | 9.33 | 9.85 | 9.72 | 9.44 | 9.65 | 9.62 | 12.64 | 6.20 | 10.96 | 10.14 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,614 | 1,878 | 2,281 | 2,861 | 3,128 | 2,583 | 3,701 | 4,525 | 4,890 | 5,483 | 7,896 | 9,072 |
| Expenses | 1,434 | 1,642 | 2,064 | 2,566 | 2,694 | 2,394 | 3,038 | 3,538 | 3,722 | 4,185 | 6,255 | 7,330 |
| Operating Profit | 180 | 236 | 217 | 295 | 434 | 189 | 664 | 987 | 1,168 | 1,298 | 1,641 | 1,742 |
| OPM % | 11% | 13% | 10% | 10% | 14% | 7% | 18% | 22% | 24% | 24% | 21% | 19% |
| Other Income | -19 | 7 | 18 | 16 | 7 | 21 | 26 | 59 | 73 | 80 | 37 | 56 |
| Interest | 33 | 28 | 55 | 81 | 94 | 82 | 76 | 84 | 112 | 163 | 266 | 285 |
| Depreciation | 76 | 80 | 100 | 137 | 186 | 184 | 183 | 210 | 241 | 278 | 448 | 520 |
| Profit before tax | 51 | 135 | 80 | 93 | 161 | -56 | 430 | 752 | 888 | 936 | 964 | 993 |
| Tax % | 59% | 39% | 36% | 37% | 26% | -75% | 20% | 19% | 11% | 16% | 16% | |
| Net Profit | 21 | 83 | 51 | 59 | 119 | -14 | 342 | 607 | 790 | 791 | 806 | 817 |
| EPS in Rs | 1.04 | 4.06 | 2.51 | 2.90 | 5.82 | -0.70 | 16.73 | 29.67 | 38.62 | 38.66 | 39.42 | 39.94 |
| Dividend Payout % | 0% | 0% | 0% | 35% | 17% | 0% | 6% | 8% | 10% | 12% | 11% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 17% | 25% | 20% | 60% | ||
| Compounded Profit Growth | 42% | 155% | 12% | 9% | ||
| Stock Price CAGR | 18% | 29% | 18% | 3% | ||
| Return on Equity | 20% | 26% | 25% | 21% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 200 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 | 204 |
| Reserves | 568 | 672 | 759 | 831 | 877 | 932 | 916 | 1,284 | 1,927 | 2,679 | 3,422 | 4,333 |
| Borrowings | 362 | 258 | 217 | 802 | 813 | 952 | 826 | 723 | 884 | 1,627 | 2,428 | 5,858 |
| Other Liabilities | 241 | 424 | 468 | 692 | 746 | 813 | 833 | 931 | 1,155 | 1,123 | 1,216 | 2,088 |
| Total Liabilities | 1,371 | 1,557 | 1,648 | 2,529 | 2,640 | 2,901 | 2,779 | 3,143 | 4,170 | 5,633 | 7,271 | 12,482 |
| Fixed Assets | 913 | 1,054 | 1,082 | 1,848 | 1,838 | 2,092 | 1,961 | 1,980 | 2,336 | 2,651 | 4,266 | 7,796 |
| CWIP | 20 | 14 | 53 | 35 | 56 | 12 | 20 | 67 | 259 | 514 | 86 | 292 |
| Investments | 52 | 87 | 96 | 9 | 17 | 86 | 120 | 132 | 252 | 844 | 1,084 | 573 |
| Other Assets | 385 | 402 | 417 | 637 | 729 | 711 | 678 | 964 | 1,323 | 1,624 | 1,835 | 3,822 |
| Total Assets | 1,371 | 1,557 | 1,648 | 2,529 | 2,640 | 2,901 | 2,779 | 3,143 | 4,170 | 5,633 | 7,271 | 12,482 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 77 | 174 | 219 | 182 | 279 | 443 | 304 | 485 | 1,085 | 1,067 | 986 | 1,621 |
| Cash from Investing Activity | -223 | -150 | -146 | -520 | -162 | -189 | -113 | -267 | -1,176 | -1,458 | -1,325 | -3,648 |
| Cash from Financing Activity | 140 | 18 | -45 | 315 | -27 | -247 | -194 | -159 | 88 | 488 | 544 | 2,340 |
| Net Cash Flow | -6 | 42 | 28 | -22 | 89 | 7 | -2 | 59 | -4 | 97 | 205 | 313 |
| Free Cash Flow | -15 | 86 | 85 | -20 | 129 | 329 | 235 | 235 | 563 | 99 | -93 | 753 |
| CFO/OP | 78% | 116% | 108% | 100% | 113% | 117% | 133% | 83% | 119% | 99% | 86% | 108% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 38 | 34 | 30 | 45 | 34 | 31 | 39 | 43 | 35 | 31 | 37 | 30 |
| Inventory Days | 56 | 48 | 45 | 56 | 48 | 35 | 32 | 30 | 31 | 44 | 40 | 42 |
| Days Payable | 146 | 152 | 173 | 200 | 177 | 177 | 221 | 180 | 224 | 214 | 185 | 248 |
| Cash Conversion Cycle | -51 | -70 | -98 | -100 | -95 | -111 | -150 | -108 | -158 | -138 | -108 | -176 |
| Working Capital Days | -30 | -12 | -11 | -10 | -10 | -22 | -38 | -16 | -25 | -30 | -17 | -19 |
| ROCE % | 7% | 9% | 14% | 9% | 9% | 14% | 2% | 25% | 32% | 26% | 21% | 16% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 63.85% | 63.85% | 63.85% | 63.85% | 63.85% | 63.85% | 63.85% | 63.85% | 63.85% | 63.27% | 63.27% | 63.27% |
| FIIs | 11.59% | 11.51% | 10.91% | 10.01% | 9.69% | 9.45% | 9.66% | 10.46% | 10.49% | 11.10% | 9.98% | 9.40% |
| DIIs | 10.89% | 10.23% | 9.51% | 8.22% | 7.90% | 8.68% | 8.52% | 8.09% | 7.76% | 7.91% | 9.14% | 9.05% |
| Government | 0.00% | 0.00% | 0.01% | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 13.05% | 13.78% | 15.12% | 17.29% | 17.94% | 17.39% | 17.34% | 16.98% | 17.29% | 17.09% | 16.98% | 17.65% |
| Others | 0.62% | 0.62% | 0.62% | 0.62% | 0.62% | 0.62% | 0.62% | 0.62% | 0.62% | 0.62% | 0.62% | 0.62% |
| No. of Shareholders | 1,02,994 | 1,20,506 | 1,38,052 | 1,60,686 | 1,78,356 | 1,77,792 | 1,85,787 | 2,05,639 | 2,26,480 | 2,28,123 | 2,20,561 | 2,11,173 |
Fundamentals
Market Cap₹ 36,579 Cr.
Current Price₹ 1,790
Stock P/E42.4
Book Value₹ 222
ROCE15.5 %
ROE20.5 %
Dividend Yield0.25 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)60%
Compounded Profit Growth (TTM)9%
Consolidated figures.
Valuation
Market capRs 35,587 Cr
Enterprise valueRs 39,316 Cr
P/E (TTM)43.61x
Price to book7.84x
Price to sales3.92x
EV / EBITDA21.86x
EV / EBIT30.75x
EV / sales4.33x
Price to cash flow21.95x
Earnings yield2.29%
Dividend yield0.26%
P/E, 3-year average39.24x
P/B, 3-year average8.62x
P/E, 5-year average37.67x
P/B, 5-year average8.70x
Profitability
Operating margin (excl. other income)20.78%
Operating margin (incl. other income)21.25%
EBITDA margin19.82%
Pre-tax margin10.95%
Net profit margin9.00%
Net margin, latest quarter7.72%
ROE19.74%
ROCE14.96%
ROA8.16%
ROE, 3-year average25.16%
ROCE, 3-year average20.78%
ROA, 3-year average12.17%
ROE, 5-year average27.04%
ROCE, 5-year average23.73%
ROA, 5-year average12.93%
ROIC (approx.)12.93%
Tax rate16.42%
Other income / net worth0.81%
Growth
Sales growth (latest year)44.01%
Profit growth (latest year)1.95%
Sales CAGR, 3 years20.39%
Sales CAGR, 5 years25.04%
Profit CAGR, 3 years9.94%
Sales growth QoQ3.46%
Profit growth QoQ-7.46%
Sales growth YoY (latest quarter)78.05%
Profit growth YoY (latest quarter)5.35%
Per share
EPS (TTM)Rs 39.94
EPS (latest year)Rs 39.42
EPS (latest quarter)Rs 10.14
EPS, 3-year averageRs 38.90
EPS, 5-year averageRs 32.62
Book value per shareRs 222.02
Sales per shareRs 443.94
Cash flow per shareRs 79.33
Free cash flow per shareRs 36.85
Dividend per share (latest year)Rs 4.50
Dividend per share, 3-year averageRs 4.33
Dividend per share, 5-year averageRs 3.30
Dividends
Dividend payout11.42%
Dividend payout, 3-year average11.14%
Dividend payout, 5-year average9.56%
Efficiency
Asset turnover0.63x
Fixed asset turnover1.01x
Inventory turnover13.10x
Inventory days28 days
Debtor days30 days
Debtors turnover12.04x
Creditor days248 days
Cash conversion cycle-176 days
Working capital days-19 days
Leverage
Total debtRs 5,858 Cr
Cash and bankRs 2,129 Cr
Net debtRs 3,728 Cr
Debt to equity1.29x
Net debt / EBITDA2.07x
Interest coverage4.48x
Current ratio (filing 2026-03-31)2.15x
Quick ratio (filing 2026-03-31)2.07x
Trade payables (filing 2026-03-31)Rs 1,032 Cr
Owners' fund to total sources36.35%
Debt to assets46.93%
Cash flow
Cash from Operating Activity (latest year)Rs 1,621 Cr
Cash from Investing Activity (latest year)Rs -3,648 Cr
Cash from Financing Activity (latest year)Rs 2,340 Cr
Net Cash Flow (latest year)Rs 313 Cr
Free cash flow (latest year)Rs 753 Cr
FCFE (approx.: FCF + change in debt)Rs 4,182 Cr
Cash from ops / profit, 5 years1.57x
Sales to cash flow4.87x
Statement figures
Net sales (TTM)Rs 9,072 Cr
Net sales (latest year)Rs 7,896 Cr
Sales (latest quarter)Rs 2,684 Cr
Operating profit excl. other income (latest year)Rs 1,641 Cr
Operating profit (latest quarter)Rs 468 Cr
Other income (TTM)Rs 56 Cr
EBITDA (TTM)Rs 1,798 Cr
PBDT (TTM)Rs 1,513 Cr
Profit before tax (TTM)Rs 993 Cr
Tax (latest year)Rs 158 Cr
Net profit (TTM)Rs 816 Cr
Net profit (latest year)Rs 806 Cr
Net profit (latest quarter)Rs 207 Cr
Depreciation (TTM)Rs 520 Cr
Depreciation (latest quarter)Rs 156 Cr
Interest (TTM)Rs 285 Cr
Cost of goods sold (latest year)Rs 2,277 Cr
Total expenditure (latest year)Rs 6,255 Cr
Total income (latest year)Rs 7,933 Cr
Share capitalRs 204 Cr
ReservesRs 4,333 Cr
Shareholders' fundsRs 4,537 Cr
Total assetsRs 12,482 Cr
Net blockRs 7,796 Cr
Capital work in progressRs 292 Cr
InvestmentsRs 573 Cr
ReceivablesRs 656 Cr
InventoryRs 174 Cr
Other liabilitiesRs 2,088 Cr
Shares outstanding (crore)20.44
Ownership
Promoter holding63.27% (-0.58 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 43.6 is at the 26th percentile of its own 8.4-year range
(median 49.8, low 31.2, high 130.5).
P/B 7.84 is at the 40th percentile (median 8.94).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | NH | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -7.3% | -2.8% | -4.5 pts |
| 1 month | -10.2% | -6.8% | -3.4 pts |
| 3 months | -13.1% | -7.6% | -5.4 pts |
| 6 months | +8.5% | +0.4% | +8.1 pts |
| 1 year | +1.2% | -9.9% | +11.1 pts |
| 2 years | +41.6% | -13.6% | +55.2 pts |
| 3 years | +60.4% | +14.2% | +46.2 pts |
| 5 years | +242.9% | +27.9% | +215.0 pts |
79 mutual fund schemes hold about ₹3,342 Cr.
Over three months 60 bought more and 7 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| Mirae Asset Large & Midcap Fund | 1.74% | 797 | +16% |
| Mirae Asset Midcap Fund | 2.12% | 444 | +25% |
| Parag Parikh Flexi Cap Fund | 0.26% | 381 | +8% |
| Axis Small Cap Fund | 1.01% | 317 | +4% |
| Mirae Asset ELSS Tax Saver Fund | 1.10% | 291 | +100% |
| DSP Small Cap Fund | 0.90% | 194 | +42% |
| Nippon India Small Cap Fund | 0.22% | 180 | +6% |
| Nippon India Pharma Fund | 1.66% | 157 | +6% |
| Mirae Asset Multicap Fund | 1.66% | 93 | +17% |
| Mirae Asset Small Cap Fund | 1.26% | 72 | -6% |
| Bandhan Small Cap Fund | 0.13% | 44 | -7% |
| Mirae Asset Flexi Cap Fund | 0.98% | 44 | +5% |
| WOC Mid Cap Fund | 0.56% | 42 | -8% |
| Aditya Birla SL Business Cycle Fund | 1.85% | 34 | +5% |
| Mirae Asset Healthcare Fund | 0.91% | 32 | -14% |
| Nippon India Nifty Smallcap 250 Index Fund | 0.60% | 21 | +7% |
| Parag Parikh ELSS Tax Saver Fund | 0.36% | 20 | +11% |
| Baroda BNP Paribas India Consumption Fund | 1.31% | 19 | +8% |
| WOC Pharma and Healthcare Fund | 1.76% | 16 | +16% |
| WOC Multi Cap Fund | 0.30% | 12 | -2% |
| Axis Nifty Smallcap 50 Index Fund | 1.60% | 12 | +2% |
| Groww Small Cap Fund | 1.43% | 11 | +100% |
| SBI Nifty Smallcap 250 Index Fund | 0.60% | 11 | +7% |
| Taurus Flexi Cap Fund | 2.67% | 10 | +2% |
| Bandhan Healthcare Fund | 2.59% | 9 | +95% |
Red flags
F-score 4 of 8No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Insider trades
NSE insider and takeover-code disclosures| Date | Who | Role | Side | Shares | Value | How |
|---|---|---|---|---|---|---|
| 2025-11-25 | Shakuntala Shetty | Promoters | sell | 1,177,000 | Rs 230.70 Cr | Market Sale |
| 2024-11-11 | Shakuntala Shetty | Promoters | other | 10,218,040 | Inter-se-Transfer | |
| 2024-11-11 | Ameya Shetty | Promoter Group | other | 10,218,040 | Inter-se-Transfer | |
| 2022-12-01 | Ameya Shetty | Promoter Group | other | 8,174,432 | Inter-se-Transfer | |
| 2022-12-01 | Dr. Anesh Shetty | Promoter Group | other | 8,174,432 | Inter-se-Transfer | |
| 2022-12-01 | Dr. Varun Shetty | Promoter Group | other | 8,174,432 | Inter-se-Transfer | |
| 2022-12-01 | Viren Prasad Shetty | Promoter Group | other | 8,174,432 | Inter-se-Transfer | |
| 2022-12-01 | Dr. Devi Prasad Shetty | Promoters | other | 32,697,728 | Inter-se-Transfer | |
| 2021-02-15 | Anil Kumar K | Employees/Designated Employe | sell | 6,940 | Rs 0.33 Cr | Market Sale |
| 2020-09-09 | Sunil Kumar C N | Employees/Designated Employe | other | 4,396 | Rs 0.14 Cr | ESOP |
| 2019-12-26 | Raghavan Venkatesh | Employees/Designated Employe | other | 4,396 | Rs 0.13 Cr | ESOP |
| 2019-09-03 | Ameya Shetty | Immediate relative | other | 2,043,608 | Inter-se-Transfer |
Latest disclosed trades by insiders, promoters and large holders. Grants, option exercises and pledges show as "other". A filing is a fact, not a signal on its own.
Latest quarter
Jun 2026Sales ₹2,684 Cr +78.1% vs Jun 2025.
Net profit ₹207 Cr +5.1%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Apollo Hospitals Enterprise Ltd | 124,503 | 59.2 | 17.4 % |
| Manipal Health Enterprises Ltd | 98,357 | 111 | 12.1 % |
| Max Healthcare Institute Ltd | 95,589 | 63.8 | 14.7 % |
| Aster DM Quality Care Ltd | 63,976 | 177 | 11.6 % |
| Fortis Healthcare Ltd | 62,058 | 58.2 | 13.4 % |
| Global Health Ltd | 38,048 | 66.4 | 17.4 % |
| Krishna Institute of Medical Sciences Ltd | 32,336 | 155 | 9.50 % |
| Dr Agarwals Health Care Ltd | 15,701 | 106 | 10.9 % |
| Rainbow Childrens Medicare Ltd | 13,892 | 48.5 | 17.4 % |
| Park Medi World Ltd | 11,898 | 42.8 | 19.5 % |
| Yatharth Hospital & Trauma Care Services Ltd | 10,676 | 58.9 | 12.9 % |
| Healthcare Global Enterprises Ltd | 10,505 | 218 | 8.30 % |
| Jupiter Life Line Hospitals Ltd | 8,591 | 44.9 | 14.8 % |
| Kovai Medical Center & Hospital Ltd | 6,579 | 25.7 | 22.6 % |
| Artemis Medicare Services Ltd | 5,818 | 50.4 | 14.5 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2026-07-17 | Dividend - Rs 4.50 Per Share | |
| 2025-08-01 | Dividend - Rs 4.50 Per Share | |
| 2024-08-02 | Dividend - Rs 4 Per Share | |
| 2023-07-07 | Dividend - Rs 2.50 Per Share | |
| 2022-08-22 | Dividend - Rs 1 Per Share | |
| 2020-03-11 | Interim Dividend - Re 1 Per Share | |
| 2019-08-01 | Dividend - Re 1 Per Share |
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Narayana Hrudayalaya Ltd?
Narayana Hrudayalaya Ltd (NH) has a market capitalisation of Rs 36,579 Cr. at the 2026-10-01 close.
What is the P/E ratio of Narayana Hrudayalaya Ltd?
Narayana Hrudayalaya Ltd trades at a P/E of 42.4 on trailing twelve-month profit, at the 2026-10-01 close.
What were Narayana Hrudayalaya Ltd's latest quarterly results?
In the Jun 2026 quarter, Narayana Hrudayalaya Ltd sales was Rs 2,684 Cr (+78.1% vs Jun 2025) and net profit was Rs 207 Cr.
What is the 52-week high and low of Narayana Hrudayalaya Ltd?
The 52-week high is Rs 2,093.30 and the 52-week low is Rs 1,589.00.